
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vesicular Antibodies: A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy
Xue Liu, Chao Liu, Zizheng Zheng, et al.
Advanced Materials (2019) Vol. 31, Iss. 17
Closed Access | Times Cited: 82
Xue Liu, Chao Liu, Zizheng Zheng, et al.
Advanced Materials (2019) Vol. 31, Iss. 17
Closed Access | Times Cited: 82
Showing 26-50 of 82 citing articles:
Amplifying Dendritic Cell Activation by Bioinspired Nanometal Organic Frameworks for Synergistic Sonoimmunotherapy
Zhixiang Lu, Shuang Bai, Yonghe Jiang, et al.
Small (2022) Vol. 18, Iss. 44
Closed Access | Times Cited: 31
Zhixiang Lu, Shuang Bai, Yonghe Jiang, et al.
Small (2022) Vol. 18, Iss. 44
Closed Access | Times Cited: 31
Blood Clot Scaffold Loaded with Liposome Vaccine and siRNAs Targeting PD-L1 and TIM-3 for Effective DC Activation and Cancer Immunotherapy
Yitong Chen, Yue Zhang, Beilei Wang, et al.
ACS Nano (2022) Vol. 17, Iss. 1, pp. 760-774
Closed Access | Times Cited: 30
Yitong Chen, Yue Zhang, Beilei Wang, et al.
ACS Nano (2022) Vol. 17, Iss. 1, pp. 760-774
Closed Access | Times Cited: 30
Recent Advancements of Aptamers in Cancer Therapy
Swathi Venkatesan, Kaushik Chanda, M. M. Balamurali
ACS Omega (2023) Vol. 8, Iss. 36, pp. 32231-32243
Open Access | Times Cited: 20
Swathi Venkatesan, Kaushik Chanda, M. M. Balamurali
ACS Omega (2023) Vol. 8, Iss. 36, pp. 32231-32243
Open Access | Times Cited: 20
A Bioengineered Nanovesicle Vaccine Boosts T‐B cell Interaction for Immunotherapy of Echinococcus multilocularis
Xiaoyu An, Wei Xiang, Xue Liu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 13
Closed Access | Times Cited: 8
Xiaoyu An, Wei Xiang, Xue Liu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 13
Closed Access | Times Cited: 8
Converting Immune Cold into Hot by Biosynthetic Functional Vesicles to Boost Systematic Antitumor Immunity
Ming Wu, Dongye Zheng, Da Zhang, et al.
iScience (2020) Vol. 23, Iss. 7, pp. 101341-101341
Open Access | Times Cited: 43
Ming Wu, Dongye Zheng, Da Zhang, et al.
iScience (2020) Vol. 23, Iss. 7, pp. 101341-101341
Open Access | Times Cited: 43
Biomaterials‐Based Delivery of Therapeutic Antibodies for Cancer Therapy
Qian‐Ni Ye, Yue Wang, Song Shen, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 11
Closed Access | Times Cited: 38
Qian‐Ni Ye, Yue Wang, Song Shen, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 11
Closed Access | Times Cited: 38
Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy
Hu Chen, Pengfei Zhang, Yesi Shi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Hu Chen, Pengfei Zhang, Yesi Shi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer Treatment
Xin Yu, Chao Fang, Kun Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1581-1581
Open Access | Times Cited: 24
Xin Yu, Chao Fang, Kun Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1581-1581
Open Access | Times Cited: 24
Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy
Jianzhong Zhang, Xue Liu, Yutian Xia, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 14
Jianzhong Zhang, Xue Liu, Yutian Xia, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 14
Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy
Liyan Li, Qianwei Miao, Fanqiang Meng, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 6033-6043
Open Access | Times Cited: 29
Liyan Li, Qianwei Miao, Fanqiang Meng, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 6033-6043
Open Access | Times Cited: 29
Research progress of tumor targeted drug delivery based on PD-1/PD-L1
Dongzhu Liu, Shan Gao, Yujia Zhai, et al.
International Journal of Pharmaceutics (2022) Vol. 616, pp. 121527-121527
Closed Access | Times Cited: 22
Dongzhu Liu, Shan Gao, Yujia Zhai, et al.
International Journal of Pharmaceutics (2022) Vol. 616, pp. 121527-121527
Closed Access | Times Cited: 22
Extracellular vesicles: powerful candidates in nano-drug delivery systems
Xiaofei Liu, Yinfang Cao, Shuming Wang, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 2, pp. 295-311
Closed Access | Times Cited: 12
Xiaofei Liu, Yinfang Cao, Shuming Wang, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 2, pp. 295-311
Closed Access | Times Cited: 12
Nanotechnology for tau pathology in Alzheimer's disease
Rongrong Ma, Qianwen Mu, Yue Xi, et al.
Materials Today Bio (2024) Vol. 27, pp. 101145-101145
Open Access | Times Cited: 4
Rongrong Ma, Qianwen Mu, Yue Xi, et al.
Materials Today Bio (2024) Vol. 27, pp. 101145-101145
Open Access | Times Cited: 4
Epigenetically Reprogrammed Nanovesicles as Inverse Vaccines for Antigen-Specific Immune Tolerance in Autoimmune Diseases
Yue Xi, Hui Feng, Xue Liu, et al.
Nano Letters (2025)
Closed Access
Yue Xi, Hui Feng, Xue Liu, et al.
Nano Letters (2025)
Closed Access
Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
Tianchuan Zhu, Yuchen Xiao, Xiaojun Meng, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Tianchuan Zhu, Yuchen Xiao, Xiaojun Meng, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly
Yesi Shi, Gan Lin, Huili Zheng, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Yesi Shi, Gan Lin, Huili Zheng, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature
Huimin Kong, Ke Yi, Chunxiong Zheng, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 36, pp. 6841-6858
Closed Access | Times Cited: 18
Huimin Kong, Ke Yi, Chunxiong Zheng, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 36, pp. 6841-6858
Closed Access | Times Cited: 18
Cellular vesicles expressing PD-1-blocking scFv reinvigorate T cell immunity against cancer
Tianyuan Xue, Zhirang Zhang, Tianliang Fang, et al.
Nano Research (2022) Vol. 15, Iss. 6, pp. 5295-5304
Closed Access | Times Cited: 18
Tianyuan Xue, Zhirang Zhang, Tianliang Fang, et al.
Nano Research (2022) Vol. 15, Iss. 6, pp. 5295-5304
Closed Access | Times Cited: 18
Engineered IL-15/IL-15Rα -expressing cellular vesicles promote T cell anti-tumor immunity
Wenli Fang, Liyan Li, Lin Zhong-da, et al.
Extracellular Vesicle (2022) Vol. 2, pp. 100021-100021
Open Access | Times Cited: 16
Wenli Fang, Liyan Li, Lin Zhong-da, et al.
Extracellular Vesicle (2022) Vol. 2, pp. 100021-100021
Open Access | Times Cited: 16
Targeted Nanophotoimmunotherapy Potentiates Cancer Treatment by Enhancing Tumor Immunogenicity and Improving the Immunosuppressive Tumor Microenvironment
Kunwei Li, Dan Yang, Dechun Liu
Bioconjugate Chemistry (2023) Vol. 34, Iss. 2, pp. 283-301
Closed Access | Times Cited: 10
Kunwei Li, Dan Yang, Dechun Liu
Bioconjugate Chemistry (2023) Vol. 34, Iss. 2, pp. 283-301
Closed Access | Times Cited: 10
Recent Advances of Engineered Cell Membrane‐Based Nanotherapeutics to Combat Inflammatory Diseases
Jiaxin Ma, Linyu Ding, Xuqi Peng, et al.
Small (2024) Vol. 20, Iss. 28
Closed Access | Times Cited: 3
Jiaxin Ma, Linyu Ding, Xuqi Peng, et al.
Small (2024) Vol. 20, Iss. 28
Closed Access | Times Cited: 3
Artificial Nanovesicles Derived from Cells: A Promising Alternative to Extracellular Vesicles
Saiyun Lou, Wei Hu, Pengyao Wei, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 3
Saiyun Lou, Wei Hu, Pengyao Wei, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 3
Cell membrane-encapsulated nanoparticles for vaccines and immunotherapy
Wei Xiang, Xue Liu, Lili Zhang, et al.
Particuology (2021) Vol. 64, pp. 35-42
Open Access | Times Cited: 21
Wei Xiang, Xue Liu, Lili Zhang, et al.
Particuology (2021) Vol. 64, pp. 35-42
Open Access | Times Cited: 21
An enzyme-responsive and NIR-triggered lipid–polymer hybrid nanoplatform for synergistic photothermal/chemo cancer therapy
Lu Tang, Qiaqia Xiao, Yue Yin, et al.
Biomaterials Science (2022) Vol. 10, Iss. 9, pp. 2370-2383
Closed Access | Times Cited: 15
Lu Tang, Qiaqia Xiao, Yue Yin, et al.
Biomaterials Science (2022) Vol. 10, Iss. 9, pp. 2370-2383
Closed Access | Times Cited: 15
Biomimetic Nanotechnology for SARS-CoV-2 Treatment
Shuo Li, Xue Liu, Gang Liu, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 596-596
Open Access | Times Cited: 8
Shuo Li, Xue Liu, Gang Liu, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 596-596
Open Access | Times Cited: 8